Sodium ethyl xanthate °C. It is the conjugate base of the unknown strong acid with p"K" of 1.6 and p"K" estimated as 12.4 for the conjugate base. Sodium ethyl xanthate easily adsorbs on the surface of solid sulfides. Xanthate are susceptible to hydrolysis and oxidation: These reactions require acidic conditions. Sodium ethyl xanthate can be identified through optical absorption peaks in the infrared (1179, 1160, 1115, 1085 cm) and ultraviolet (300 nm) ranges. There are at least six chemical detection methods: Sodium ethyl xanthate can also be quantified using gravimetry, by weighing the lead xanthate residue obtained after reacting SEX with 10% solution
Ethyl loflazepate Ethyl loflazepate Ethyl loflazepate (marketed under the brand names Meilax, Ronlax and Victan) is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. In animal studies it was found to have low toxicity, although in rats evidence of pulmonary phospholipidosis occurred with pulmonary foam cells developing with long-term use of very high doses. Its elimination half-life is 51–103 hours. Its mechanism of action is similar to other benzodiazepines. Ethyl loflazepate also produces an active metabolite which is stronger than the parent compound. Ethyl loflazepate was designed to be a prodrug for descarboxyloflazepate,